Unknown human safety: Injectable GHK-Cu has no completed human safety data, so treat it as experimental
Link Sikiric P, et al
Other ingredients Water (aqua), glycerin, glycereth-26, butylene glycol, methylpropanediol, vinyl dimethicone, niacinamide, 1,2-hexanediol, betaine, isononyl isononanoate, isohexadecane, sodium polyacrylate, ammonium acryloyldimethyltaurate/vp copolymer, phenyltrimethicone, dimethiconol, fragrance, chondrus crispus powder, c18-21 alkane, glutathione, ethylhexylglycerin, polyglyceryl-10 laurate, glyceryl acrylate/acrylic acid copolymer, agar, xanthan gum, hydrogenated lecithin, polyglyceryl-10 oleate, adenosine, tromethamine, acrylates/c10-30 alkyl acrylate crosspolymer, glucose, limonene, gellan gum, thioctic acid, caprylic/capric triglyceride, ceramide np, sorbitan laurate, hydroxyethylcellulose, acetyl dipeptide-1 cetyl ester, palmitoyl tripeptide-5, acetyl hexapeptide-1, soluble collagen
Severe hypoglycemia caused 4 hospital-grade seizures or loss-of-consciousness events out of 71 patients in the Increlex program it is not a theoretical risk
This method bypasses the oral route where medicines and supplements often are not capable of being fully absorbed and used by the body
